Nutrients published a new post-hoc analysis of the 1-year MenaQ7 cardiovascular study, examining an underrepresented population and demonstrating a promotion of healthy blood pressure through a reduction in vascular stiffness.
A new post-hoc analysis of a 1-year cardiovascular study on the vitamin K2 supplement MenaQ7® has uncovered promising findings for women’s heart health. The study, published in the journal Nutrients, specifically examined the effects of vitamin K2 MK-7 supplementation on vascular stiffness and blood pressure in pre-, peri-, and post-menopausal women with low vitamin K status.
The results showed that for post-menopausal women with high baseline vascular stiffness, vitamin K2 MK-7 supplementation significantly improved vascular flexibility and reduced blood pressure in the brachial and carotid arteries. In contrast, post-menopausal women in the placebo group with high baseline stiffness exhibited increased blood pressure. These findings suggest vitamin K2 MK-7 may be an effective intervention for mitigating the negative cardiovascular effects that can occur with menopause.
Importantly, the researchers note that the benefits of vitamin K2 MK-7 were not uniform across all participants. Those with elevated arterial stiffness experienced the greatest improvements, underscoring the importance of personalized approaches to cardiovascular health. These new insights build on previous clinical trials demonstrating the vascular health benefits of MenaQ7® vitamin K2, further validating its potential as a targeted supplement for supporting women’s heart health, particularly during the menopausal transition.